Clinical Trials Arena August 28, 2024
GlobalData

The number of new oesophageal cancer cases annually is projected to increase by 80% before 2050. Find out about current and developing treatments set to improve patient outcomes.

Oesophageal cancer is the 11th most diagnosed cancer and the 7th leading cause of cancer mortality. The disease starts in the oesophagus, the tube that moves food from the throat to the stomach, but symptoms often remain unnoticed until the cancer spreads. The two main types, oesophageal adenocarcinoma, and oesophageal squamous cell carcinoma, develop in different oesophageal regions and are driven by distinct genetic changes.

The prevalence of oesophageal cancer

Oesophageal cancer is more common in men than women, with global Age Standardised Incidence Rates (ASIR) of 7.6 and 2.6 respectively. The...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Clinical Trials, Trends
FDA approves clinical trials for pig organ transplants
Transforming Clinical Trials with Alexander Saint-Amand
The New Product Development Landscape: Navigating the Challenges
Lindus Health completes $55m funding round
Bridging Clinical Research Gaps: How Site Augmentation Enhances Trial Success

Share This Article